Hypertension recientes

Hypertension recientes 2017-01-13T09:52:48+00:00

Project Description

Hypertension - recientes

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [Clinical Practice Guideline]
9/5/2018
Paul K. Whelton, Robert M. Carey, Wilbert S. Aronow, Donald E. Casey, Jr, Karen J. Collins, Cheryl Dennison Himmelfarb, Sondra M. DePalma, Samuel Gidding, Kenneth A. Jamerson, Daniel W. Jones, Eric J. MacLaughlin, Paul Muntner, Bruce Ovbiagele, Sidney C. Smith, Jr, Crystal C. Spencer, Randall S. Stafford, Sandra J. Taler, Randal J. Thomas, Kim A. Williams, Sr, Jeff D. Williamson, Jackson T. Wright, Jr
ver resumen

Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [Systematic Review]
9/5/2018
David M. Reboussin, Norrina B. Allen, Michael E. Griswold, Eliseo Guallar, Yuling Hong, Daniel T. Lackland, Edgar (Pete) R. Miller III, Tamar Polonsky, Angela M. Thompson-Paul, Suma Vupputuri
ver resumen
Objective—To review the literature systematically and perform meta-analyses to address these questions: 1) Is there evidence that self-measured blood pressure (BP) without other augmentation is superior to office-based measurement of BP for achieving better BP control or for preventing adverse clinical outcomes that are related to elevated BP? 2) What is the optimal target for BP lowering during antihypertensive therapy in adults? 3) In adults with hypertension, how do various antihypertensive drug classes differ in their benefits and harms compared with each other as first-line therapy?Methods—Electronic literature searches were performed by Doctor Evidence, a global medical evidence software and services company, across PubMed and EMBASE from 1966 to 2015 using key words and relevant subject headings for randomized controlled trials that met eligibility criteria defined for each question. We performed analyses using traditional frequentist statistical and Bayesian approaches, including random-effects Bayesian network meta-analyses.Results—Our results suggest that: 1) There is a modest but significant improvement in systolic BP in randomized controlled trials of self-measured BP versus usual care at 6 but not 12 months, and for selected patients and their providers self-measured BP may be a helpful adjunct to routine office care. 2) systolic BP lowering to a target of <130 mm Hg may reduce the risk of several important outcomes including risk of myocardial infarction, stroke, heart failure, and major cardiovascular events. No class of medications (ie, angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, calcium channel blockers, or beta blockers) was significantly better than thiazides and thiazide-like diuretics as a first-line therapy for any outcome.

Correction to: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [Correction]
9/5/2018
ver resumen

Correction to: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [Correction]
9/5/2018
ver resumen

Correction to: Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [Correction]
9/5/2018
ver resumen

Clinical Implications [Clinical Implications]
9/5/2018
ver resumen

Case of Severe Hypertension and Nephrotic Range Proteinuria [Clinical-Pathological Conference]
9/5/2018
Michael Bursztyn, Rhian M. Touyz, Cheryl L. Laffer, Robert M. Carey, Anna F. Dominiczak
ver resumen

Hypertension Editors Welcome Comments From Regional Hypertension Societies [Guidelines Conversation]
9/5/2018
Anna F. Dominiczak, Rhian M. Touyz
ver resumen

Blood Pressure Measurement and Hypertension Diagnosis in the 2017 US Guidelines [Guidelines Conversation]
9/5/2018
George Stergiou, Paolo Palatini, Roland Asmar, Aleȷandro de la Sierra, Martin Myers, Andrew Shennan, Jiguang Wang, Eoin O’Brien, Gianfranco Parati
ver resumen

Treatment Thresholds and Targets in Hypertension [Guidelines Conversation]
9/5/2018
Costas Tsioufis, Costas Thomopoulos, Reinhold Kreutz
ver resumen

Blood Pressure Management [Guidelines Conversation]
9/5/2018
Daniel W. Jones
ver resumen

Blood Pressure Down Under, but Down Under What? [Guidelines Conversation]
9/5/2018
Erin Hoare, Bronwyn A. Kingwell, Garry L.R. Jennings
ver resumen

Hypertension Guidelines in the United States and Canada: Are We Getting Closer? [Guidelines Conversation]
9/5/2018
Stella S. Daskalopoulou, Doreen M. Rabi, Ernesto L. Schiffrin, Ross D. Feldman, Raj S. Padwal, Guy Tremblay, Nadia A. Khan
ver resumen

Could 130/80 mm Hg Be Adopted as the Diagnostic Threshold and Management Goal of Hypertension in Consideration of the Characteristics of Asian Populations? [Guidelines Conversation]
9/5/2018
Kazuomi Kario, Ji-Guang Wang
ver resumen

Global Implications of Blood Pressure Thresholds and Targets [Guidelines Conversation]
9/5/2018
Daniel T. Lackland, Lawrence J. Beilin, Norm R.C. Campbell, Marc G. Jaffe, Marcelo Orias, C. Venkata Ram, Michael A. Weber, Xin-Hua Zhang
ver resumen

Absolute Risk-Based Treatment Using Adaptive Blood Pressure Thresholds and Targets Is Crucial to Older Multimorbid Patients With High Fall Risk [Guidelines Conversation]
9/5/2018
Vernon Min Sen Oh
ver resumen

Sodium Handling by the Blood Vessel Wall [Brief Review]
9/5/2018
Eliane F.E. Wenstedt, Rik H.G. Olde Engberink, Liffert Vogt
ver resumen

Nocturnal Hypertension [Brief Review]
9/5/2018
Kazuomi Kario
ver resumen

Saga of Familial Hyperaldosteronism [Brief Review]
9/5/2018
Livia Lenzini, Selene Prisco, Brasilina Caroccia, Gian Paolo Rossi
ver resumen

Beneficial Effects of High Potassium [Mid-Career Award for Research Excellence]
9/5/2018
Alexander Staruschenko
ver resumen







Feed aggregation powered by Syndicate Press.
Processed request in 0.67244 seconds.

Deje su comentario

Uso de cookies

Este sitio web utiliza cookies para conseguir la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies ACEPTAR

Aviso de cookies

Envía un mensaje

Desde aquí puedes contactar con riesgovascular.org para enviarnos tus comentarios, sugerencias o cualquier otro tema que consideres oportuno

Intentaremos contestar lo antes posible.